Table 2.

Overview of study parameters and measurement points

Questionnaire	Outcome	Screening	T0	T1	T2	T3	T4
			Pre-test	Mid-treatmenta	Post-test	Follow-upb	Follow-upc
CGI-BPd	Global illness severity	X
MINI	Diagnosis BD	X
MHC-SF	Well-being	X	X	X	X	X	X
QPR	Personal recovery		X		X	X	X
s-SRPQ	Social participation		X		X	X	X
QIDS-SR	Depressive symptoms		X		X	X	X
ASRM	Manic symptoms		X		X	X	X
HADS-A	Anxiety symptoms		X		X	X	X
PANAS	Positive emotions		X	X	X
SCS-SF	Self-compassion		X	X	X
SPWB	Positive relationships		X	X	X
RPA	Dampening of positive affect		X	X	X
Telephone interviews	Relapse						X
EQ-5D-5 L	Quality of Life		X				X
TiC-P	Costs associated with psychiatric illness		X				X
Socio- demographics	Gender, age, education, marital status, living situation, ethnicity		X

^a4 weeks after intervention begin

^b6 months after baseline

^c12 months after baseline

^dclinician reported